Circassia Holdings (CIR.LN)

Late-stage biotech developing allergy vaccines.

Health Care - Biotechnology

IPO Performance
Latest Trade $0.86 0.00 (0.0%)
First Day Return -99.7%
Return from IPO -83.4%
 
Circassia Holdings IPO News more
  • .
IPO Data
IPO File Date 02/06/2014
Offer Price $5.16
Price Range $4.16 - $5.16
Offer Shares (mm) 67.4
Deal Size ($mm) 348
 
IPO Data
IPO Date 03/13/2014
Offer Price $5.16
Price Range $4.16 - $5.16
Offer Shares (mm) 67.4
Deal Size ($mm) $348
 
Underwriters
more
Business Overview
Late-stage biotech developing allergy vaccines.
Late-stage biotech developing allergy vaccines.
more
Company Data
Headquarters , , United Kingdom
Founded 2006
Employees n/a
Website
 

Performance vs. IPO Index (IPOUSA)